|
Index of reports
> Cases resulting in hospitalization (92)
Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in hospitalization.
Reports 1 - 25 of 92 Next >>
Adverse event in female receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from United States on 2007-10-29
Patient: female, weighing 9.2 kg (20.2 pounds)
Adverse reactions / side effects: Breech Delivery, Premature Baby, Congenital Anomaly, Patent Ductus Arteriosus, Joint Dislocation
Adverse event resulted in: hospitalization
Suspect drug(s):
Saquinavir
Indication: HIV Infection
Nelfinavir
Indication: HIV Infection
Start date: 2003-03-12
Nelfinavir
Abacavir Sulfate
Indication: HIV Infection
3TC
Indication: HIV Infection
Nevirapine
Indication: HIV Infection
Start date: 2003-03-12
AZT
Indication: HIV Infection
Epivir
Indication: HIV Infection
Zidovudine
Indication: HIV Infection
Start date: 2003-03-12
Dexamethasone 0.5mg TAB
Indication: Drug USE FOR Unknown Indication
Indomethacin
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Didanosine
Adverse event in 39 year old female receiving Epivir (Lamivudine)
Reported by a pharmacist from United Kingdom on 2007-10-22
Patient: 39 year old female
Adverse reactions / side effects: Mitochondrial Cytopathy, Portal Vein Thrombosis, Hepatic Failure, Lactic Acidosis, Constipation
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2001-12-01
Indinivir Sulfate
Indication: Drug USE FOR Unknown Indication
Nevirapine
Dosage: 200mg twice per day
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Septrin
Adverse event in female receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from United States on 2007-10-19
Patient: female, weighing 0.9 kg (2.0 pounds)
Adverse reactions / side effects: Breech Delivery, Premature Baby, Congenital Anomaly, Patent Ductus Arteriosus, Joint Dislocation
Adverse event resulted in: hospitalization
Suspect drug(s):
Viracept
Dosage: daily dose:2500mg-freq:daily
Administration route: Oral
Indication: HIV Infection
Ziagen
Dosage: daily dose:600mg-freq:daily
Administration route: Oral
Indication: HIV Infection
3TC
Indication: HIV Infection
Viramune
Dosage: daily dose:400mg-freq:daily
Indication: HIV Infection
Fortovase
Dosage: daily dose:2400mg
Administration route: Oral
Indication: HIV Infection
AZT
Indication: HIV Infection
Epivir
Dosage: daily dose:300mg-freq:daily
Indication: HIV Infection
Retrovir
Dosage: daily dose:600mg-freq:daily
Administration route: Oral
Indication: HIV Infection
End date: 2003-03-12
Dexamethasone 0.5mg TAB
Indocin
Other drugs received by patient: Videx
Adverse event in 44 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-10-11
Patient: 44 year old male
Adverse reactions / side effects: Optic Atrophy, Glaucoma, Optic Nerve Disorder, Drug Ineffective, Tooth Abscess, Trigeminal Neuralgia, Sciatica, Tooth Extraction, Visual Acuity Reduced, Treatment Noncompliance, Balance Disorder, Leukoencephalopathy, Depression, Optic Neuritis Retrobulbar, Facial Pain, Mononeuropathy Multiplex, Visual Disturbance, Gastrointestinal Disorder, Memory Impairment, Neuralgia
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Retrovir
Indication: HIV Infection
Start date: 2006-06-23
Telzir
Indication: HIV Infection
Start date: 2005-03-29
End date: 2006-06-23
Combivir
Indication: HIV Infection
Start date: 2005-09-28
End date: 2006-06-23
Epivir
Indication: HIV Infection
Start date: 1998-04-01
Viread
Indication: HIV Infection
Start date: 2006-06-23
Invirase
Indication: HIV Infection
Start date: 2006-06-23
Lyrica
Indication: Trigeminal Neuralgia
Start date: 2006-06-23
End date: 2006-07-01
Neurontin
Indication: Trigeminal Neuralgia
Start date: 2006-01-01
End date: 2006-01-01
Bactrim
Start date: 1998-09-01
Norvir
Indication: HIV Infection
Start date: 2004-04-17
Other drugs received by patient: Viracept; Zerit
Adverse event in 45 year old male receiving Epivir (Lamivudine)
Reported by a physician from France on 2007-10-09
Patient: 45 year old male
Adverse reactions / side effects: Hypovitaminosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Sustiva
Epivir
Tenofovir
Adverse event in 45 year old male receiving Epivir (Lamivudine)
Reported by a physician from France on 2007-10-09
Patient: 45 year old male
Adverse reactions / side effects: Hypovitaminosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Sustiva
Epivir
Tenofovir
Adverse event in male receiving Epivir (Lamivudine)
Reported by a individual with unspecified qualification from Japan on 2007-10-08
Patient: male
Adverse reactions / side effects: Nausea, Diabetes Mellitus, Diarrhoea, Hypertriglyceridaemia, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Viramune
Administration route: Oral
Indication: HIV Infection CDC Group IV Subgroup E
Start date: 1998-11-24
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-11-24
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 1998-11-24
Other drugs received by patient: Diovan
Adverse event in 61 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-07-30
Patient: 61 year old male, weighing 62.0 kg (136.4 pounds)
Adverse reactions / side effects: Renal Tubular Disorder, Blood Creatine Phosphokinase Increased, Hyperkalaemia, Parkinsonism, Muscle Rigidity, Hyperuricaemia, Neuropathy Peripheral, Mitochondrial Cytopathy, Proteinuria, Blood Creatinine Increased, Acid Base Balance Abnormal, Pain in Extremity, Folate Deficiency, Akinesia, General Physical Health Deterioration, Paraesthesia, Anaemia Macrocytic, Renal Failure, Areflexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-15
Videx
Dosage: 250mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-15
Zyprexa
Dosage: 7.5mg per day
Indication: Neuropathy
Other drugs received by patient: Reyataz; Norvir
Adverse event in 65 year old female receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-26
Patient: 65 year old female
Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly
Adverse event resulted in: hospitalization
Suspect drug(s):
Stocrin Caps
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-30
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-30
End date: 2006-04-17
Epivir
Dosage: interrupted on 17-apr-2006 restarted on 18-apr-2006 at 300mg daily
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-30
End date: 2006-04-17
Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Lansoprazole; Pentamidine Isethionate; Abacavir Sulfate
Adverse event in 65 year old female receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-07-24
Patient: 65 year old female
Adverse reactions / side effects: Dyspnoea, Palpitations, Hypothyroidism, Cardiomegaly
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-30
Zerit
Dosage: 60mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-30
End date: 2006-04-17
Stocrin
Dosage: 600mg per day
Administration route: Oral
Indication: HIV Infection
Start date: 2002-09-30
Ziagen
Dosage: 300mg twice per day
Administration route: Oral
Indication: HIV Infection
Start date: 2006-04-18
Other drugs received by patient: Euglucon; Predonine; Rimatil; Evoxac; Azulfidine; Lansoprazole; Pentamidine Isethionate; Simavastatin
Adverse event in 2 month old male receiving Epivir (Lamivudine)
Reported by a physician from France on 2007-07-16
Patient: 2 month old male
Adverse reactions / side effects: Gastrointestinal Malformation, Heart Disease Congenital, Pregnancy
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Videx
Start date: 2001-06-12
End date: 2001-08-11
Retrovir
Start date: 2001-03-27
End date: 2001-08-11
Epivir
Start date: 2001-03-27
End date: 2001-08-11
Adverse event in receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-13
Patient:
Adverse reactions / side effects: Drug Dependence
Adverse event resulted in: hospitalization
Suspect drug(s):
Viracept
Indication: HIV Infection
Epivir
Administration route: Oral
Retrovir
Administration route: Oral
Indication: HIV Infection
Morphine
Administration route: Oral
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-07-13
Patient: 32 year old male
Adverse reactions / side effects: Multi-Organ Failure, Bone Marrow Failure
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Endoxan
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Adriamycin PFS
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Oncovin
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Predonine
Administration route: Oral
Indication: Plasmablastic Lymphoma
Start date: 2006-02-23
End date: 2006-03-21
Ganciclovir Sodium
Indication: Cytomegalovirus Enterocolitis
Start date: 2006-06-30
End date: 2006-07-19
Other drugs received by patient: Pentamidine Isethionate
Adverse event in 49 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-07-06
Patient: 49 year old male
Adverse reactions / side effects: Hepatic Encephalopathy, Spinal Compression Fracture, Hepatic Failure, Cerebellar Haemorrhage, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zerit
Dosage: 80mg daily (06-sep-2001-04-jul-2004), dose decreased 60mg daily (05-jul-2004-01-feb-2005)
Administration route: Oral
Indication: HIV Infection
Start date: 2001-09-06
End date: 2005-02-01
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2001-09-06
End date: 2004-07-04
Stocrin Caps
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-11
Viracept
Administration route: Oral
Indication: HIV Infection
Start date: 2001-09-06
End date: 2004-12-06
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-07
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-07
Other drugs received by patient: Monilac; Recombinate; Octocog Alpha; Tenormin; Losartan Potassium; Adalat; Diovan; Nifedipine; Octocog Alpha; Valsartan; Lactulose
Adverse event in 66 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-06-27
Patient: 66 year old male
Adverse reactions / side effects: Hypoacusis, Pancytopenia, Otitis Media
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-12-22
End date: 2006-05-29
Ziagen
Dosage: 150mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-12-31
End date: 2006-05-29
Retrovir
Dosage: 400mg per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-12-22
End date: 2004-12-30
Kaletra
Dosage: 6cap per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-12-22
End date: 2006-05-29
Baktar
Administration route: Oral
Indication: Pneumocystis Jiroveci Pneumonia
Start date: 2004-11-18
End date: 2006-05-29
Other drugs received by patient: Benambax; Funguard; Glyceol; Decadron; Seishoku; Laxoberon; Magnesium Oxide
Adverse event in 39 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-06-26
Patient: 39 year old male
Adverse reactions / side effects: Vomiting, Neurogenic Bladder, Nasopharyngitis, Nausea, Costovertebral Angle Tenderness, Urinary Tract Infection, Pyrexia, Epilepsy, Eating Disorder, Convulsion, Ascites, Blood Potassium Decreased, Tenderness, Pyuria, Pyelonephritis
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 1996-12-18
End date: 1997-03-13
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Start date: 1998-07-10
End date: 1999-10-31
Epivir
Administration route: Oral
Start date: 1999-11-01
End date: 2003-03-31
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Start date: 2003-04-01
End date: 2003-04-26
Epivir
Dosage: 150mg twice per day
Administration route: Oral
Start date: 2004-07-28
Ziagen
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2003-04-27
End date: 2003-12-24
Ziagen
Dosage: 300mg twice per day
Administration route: Oral
Start date: 2004-05-28
End date: 2004-06-29
Ziagen
Dosage: 300mg twice per day
Administration route: Oral
Start date: 2004-12-17
Kaletra
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2004-06-30
End date: 2006-11-23
Other drugs received by patient: Kaletra
Adverse event in 35 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-26
Patient: 35 year old male
Adverse reactions / side effects: Hyperlipidaemia, Pseudomembranous Colitis, Lymphoma, Herpes Zoster
Adverse event resulted in: hospitalization
Suspect drug(s):
Efavirenz
Dosage: interrupted 11/8/00, restarted 11/16/00.
Administration route: Oral
Indication: HIV Infection
Start date: 1999-10-04
End date: 2000-11-08
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1997-05-01
End date: 1999-10-03
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-10-04
End date: 2000-11-08
Norvir
Dosage: 400 mg/bid 20jan99 to 3oct99, 200 mg/bid 9oct99 to 8nov00 then 400 mg/bid 16nov00 to cont.
Administration route: Oral
Indication: HIV Infection
Start date: 1990-10-09
End date: 2000-11-08
Ziagen
Dosage: therapy interrupted 11/8/00, restarted 11/16/00
Administration route: Oral
Indication: HIV Infection
Start date: 1999-10-04
End date: 2001-11-08
Invirase
Administration route: Oral
Indication: HIV Infection
Start date: 1990-01-18
End date: 2001-10-03
Prozei
Dosage: therapy interrupted 11/8/00, restarted 11/16/00
Administration route: Oral
Indication: HIV Infection
Start date: 1999-10-04
End date: 2001-11-08
Other drugs received by patient: Amikacin Sulfate; Ciprofloxacin; Allopurinol; Azithromycin; Ethambutol Hydrochloride; Metronidazole; Sulfamethoxazole and Trimethoprim; Clarithromycin; Polaramine; Crixivan
Adverse event in receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-06-25
Patient:
Adverse reactions / side effects: Agitation, Overdose, Body Temperature Increased, Drug Exposure During Pregnancy, Abdominal Distension, Sneezing, Feeding Disorder Neonatal, Faecaloma
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Indication: HIV Infection
Retrovir
Indication: HIV Infection
Epivir
Administration route: Oral
Indication: Antiviral Prophylaxis
Retrovir
Administration route: Oral
Indication: Antiviral Prophylaxis
Morphine
Viracept
Indication: HIV Infection
Viracept
Administration route: Oral
Indication: Antiviral Prophylaxis
Adverse event in 39 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-21
Patient: 39 year old male
Adverse reactions / side effects: Hepatic Cirrhosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
Zerit
Administration route: Oral
Indication: HIV Infection
Start date: 1998-12-21
End date: 2005-04-24
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2004-01-30
End date: 2005-04-24
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 1997-12-29
End date: 2005-04-24
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2004-07-28
End date: 2005-04-24
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2005-04-25
End date: 2005-05-23
Other drugs received by patient: NEO-Minophagen C; Factor Viii; Kogenate
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a physician from France on 2007-06-20
Patient: 32 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: Nephrolithiasis, Renal Colic
Adverse event resulted in: hospitalization
Suspect drug(s):
Videx
Administration route: Oral
Start date: 2006-12-29
Norvir
Administration route: Oral
Start date: 2006-12-29
Epivir
Administration route: Oral
Start date: 2006-12-29
Darunavir
Administration route: Oral
Start date: 2006-12-29
Raltegravir Potassium
Administration route: Oral
Start date: 2006-12-29
Adverse event in 46 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-06-20
Patient: 46 year old male, weighing 82.0 kg (180.4 pounds)
Adverse reactions / side effects: Skin Ulcer, Oedema Peripheral
Adverse event resulted in: hospitalization
Suspect drug(s):
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2007-04-26
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2007-04-26
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2007-04-26
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2007-04-26
Bactrim
Administration route: Oral
Indication: HIV Infection
Buprenorphine Chlorhydrate
End date: 2007-04-24
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-06-18
Patient: 32 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: Back Pain, Nephrolithiasis, Renal Disorder, Renal Colic, Pyelocaliectasis
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-12-29
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-12-29
Videx
Administration route: Oral
Indication: HIV Infection
Start date: 2006-12-29
Darunavir
Administration route: Oral
Indication: HIV Infection
Start date: 2006-12-29
HIV Treatments (Unspecified)
Administration route: Oral
Indication: HIV Infection
Start date: 2006-12-29
Adverse event in 37 year old male receiving Epivir (Lamivudine)
Reported by a physician from Japan on 2007-06-18
Patient: 37 year old male
Adverse reactions / side effects: Neutropenia, Rash, Cerebral Toxoplasmosis, Herpes Zoster
Adverse event resulted in: hospitalization
Suspect drug(s):
Denosine IV
Dosage: form reported as i.v. infusion.
Indication: Cytomegalovirus Enterocolitis
Start date: 2005-03-11
End date: 2005-03-29
Denosine IV
Dosage: form reported as i.v. infusion.
Start date: 2005-04-19
End date: 2005-04-24
Valixa
Administration route: Oral
Indication: Cytomegalovirus Enterocolitis
Start date: 2005-04-25
End date: 2005-05-17
Valixa
Dosage: maintenance threrapy.
Administration route: Oral
Start date: 2005-05-18
End date: 2005-07-21
Baktar
Administration route: Oral
Start date: 2005-03-12
End date: 2005-04-06
Epivir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Epivir
Administration route: Oral
Start date: 2005-06-10
Zerit
Dosage: reported as zerit (sanilvudine).
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Zerit
Dosage: reported as zerit (sanilvudine).
Administration route: Oral
Start date: 2005-06-10
End date: 2006-03-23
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2005-03-29
End date: 2005-05-06
Kaletra
Administration route: Oral
Start date: 2005-06-10
Lectisol
Dosage: reported as lectisol (diaphenylsulfone).
Administration route: Oral
Start date: 2005-06-23
End date: 2005-06-28
Other drugs received by patient: Pentamidine Isethionate; Cortril; Diflucan; Fungizone; Zithromac; Pyrimethamine TAB; Clindamycin Hydrochloride; Calcium Folinate; Lenograstim; Prednisolone
Adverse event in 46 year old male receiving Epivir (Lamivudine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-06-18
Patient: 46 year old male, weighing 82.0 kg (180.4 pounds)
Adverse reactions / side effects: Skin Ulcer, Oedema Peripheral
Adverse event resulted in: hospitalization
Suspect drug(s):
Reyataz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2007-04-26
Bactrim
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Norvir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2007-04-26
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2007-04-26
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2007-04-26
Buprenorphine HCL
End date: 2007-04-24
Adverse event in 46 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from France on 2007-06-15
Patient: 46 year old male, weighing 82.0 kg (180.4 pounds)
Adverse reactions / side effects: Skin Ulcer, Oedema Peripheral, Application Site Ulcer, Purulent Discharge
Adverse event resulted in: hospitalization
Suspect drug(s):
Epivir
Dosage: 300mg per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2007-04-26
Bactrim
Dosage: 1unit per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Norvir
Dosage: 100mg per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2007-04-26
Viread
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2007-04-26
Reyataz
Dosage: 150mg per day
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2007-04-26
Buprenorphine HCL
End date: 2007-04-24
Page 1 Next >>
|
